Finance entity
All 1 tracked stories fall under one category: earnings. pz-cel is most often covered alongside Abeona Therapeutics, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window.
Last mentioned: Mar 16, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. pz-cel is most often covered alongside Abeona Therapeutics, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window. At 5, the average consequence score sits below the same-window beat average of 6.2. We currently track 1 Finance story that mention pz-cel, all published on March 16, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 107 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering pz-cel. Shared-story counts are live from our verified record — not editorial picks.
Abeona Therapeutics and Consolidated Water are preparing to report full-year 2025 financial results, highlighting contrasting paths in the biotech and utility sectors. While Abeona faces critical regulatory milestones for its gene therapy pipeline, Consolidated Water continues to leverage infrastructure expansion to drive steady revenue growth.
pz-cel is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
